What is the recommended procedure for rapid sequence intubation (RSI) in emergency situations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rapid Sequence Intubation (RSI) in Emergency Situations

Rapid sequence intubation requires administration of a sedative-hypnotic agent followed immediately by a neuromuscular blocking agent in rapid succession, with endotracheal tube placement before any assisted ventilation, specifically designed for critically ill patients requiring emergency airway management. 1

Patient Positioning

  • Position the patient in semi-Fowler position (head and torso inclined) during RSI to reduce aspiration risk and improve first-pass intubation success. 1, 2

Preoxygenation Strategy

The preoxygenation approach depends on patient cooperation and severity of hypoxemia:

  • For cooperative patients: Use standard preoxygenation with high-flow oxygen 1
  • For severe hypoxemia (PaO2/FiO2 < 150): Use noninvasive positive pressure ventilation (NIPPV) for preoxygenation 1, 2
  • For agitated, delirious, or combative patients: Use medication-assisted preoxygenation (delayed sequence intubation) with ketamine, which increases oxygen saturation by approximately 8.9% before administering the neuromuscular blocking agent 1, 2
  • When difficult laryngoscopy is anticipated: Use high-flow nasal oxygen (HFNO) 1, 2

Gastric Decompression

  • Consider nasogastric tube decompression in patients at high risk of regurgitation when benefits outweigh risks 1

Medication Selection Algorithm

Sedative-Hypnotic Induction Agents

You must administer a sedative-hypnotic agent when using a neuromuscular blocking agent to prevent awareness during paralysis. 1, 3

For hemodynamically unstable patients:

  • Use etomidate 0.2-0.3 mg/kg as the preferred agent due to minimal cardiovascular depression 3, 2

For hemodynamically stable patients:

  • Either etomidate or ketamine 1-2 mg/kg can be used 3, 2
  • No significant mortality difference exists between etomidate and other induction agents (ketamine, midazolam, propofol) 1, 3
  • Recent evidence suggests etomidate may produce less hypotension than ketamine in patients with shock or sepsis 4

For agitated patients requiring medication-assisted preoxygenation:

  • Use ketamine 1-2 mg/kg before administering the neuromuscular blocking agent 3, 2

Neuromuscular Blocking Agents (NMBAs)

You must administer an NMBA when a sedative-hypnotic agent is used for intubation (strong recommendation). 1, 3

Choose between succinylcholine or rocuronium when no contraindications exist:

  • Succinylcholine 1-1.5 mg/kg: Rapid onset with shorter duration; preferred for hemodynamically stable patients 3, 2
  • Rocuronium 0.9-1.2 mg/kg for RSI: Provides intubating conditions in median 1 minute with 31 minutes clinical duration 3, 5
    • Critical requirement: Sugammadex must be immediately available when rocuronium is used for potential "cannot intubate/cannot oxygenate" scenarios 3, 2, 5
    • Be aware that rocuronium's longer duration may delay post-intubation analgosedation, potentially increasing awareness risk 1

Timing and Administration

  • Administer both agents in rapid succession with immediate endotracheal tube placement before assisted ventilation begins to minimize aspiration risk 3, 2
  • For rocuronium 0.6-1.2 mg/kg, excellent or good intubating conditions are achieved in most patients in less than 2 minutes 5
  • Maximum neuromuscular blockade occurs within 3 minutes for most patients 5

Dosing for Rapid Sequence Intubation

Standard RSI dosing:

  • Rocuronium 0.6-1.2 mg/kg provides excellent or good intubating conditions in less than 2 minutes 5
  • The 0.6 mg/kg dose provides approximately 31 minutes of clinical relaxation under opioid/nitrous oxide/oxygen anesthesia 5

Special Population Considerations

Obese patients:

  • Dose rocuronium based on actual body weight, not ideal body weight, as dosing by ideal body weight results in longer time to maximum block and shorter clinical duration 5

Geriatric patients (65-80 years):

  • Standard dose of 0.6 mg/kg provides excellent to good intubating conditions in median 2.3 minutes 5
  • Recovery times are not prolonged compared to younger adults 5

Obstetric patients:

  • Rocuronium is NOT recommended for rapid sequence induction in Cesarean section patients due to inadequate intubating conditions when used with lower thiopental doses 5

Common Pitfalls and How to Avoid Them

  • Inadequate preoxygenation: Ensure proper technique and use medication-assisted preoxygenation for uncooperative patients 1, 2
  • Failure to have backup airway equipment: Immediately available equipment is essential for "cannot intubate/cannot oxygenate" scenarios 2
  • Inappropriate medication selection: Choose etomidate for hemodynamically unstable patients to avoid cardiovascular collapse 3, 2
  • Delayed post-intubation sedation: When using rocuronium, anticipate its longer duration and plan for timely post-intubation analgosedation 1
  • Medication errors: Store rocuronium with cap and ferrule intact to minimize wrong product selection, as accidental administration of neuromuscular blocking agents may be fatal 5

Post-Intubation Management

  • Apply PEEP of at least 5 cmH₂O after intubation of hypoxemic patients 1
  • Use post-intubation recruitment maneuvers in hypoxemic patients 1
  • Include cardiovascular monitoring with defined parameters for fluid challenges and early vasopressor use to prevent hemodynamic instability 1

References

Guideline

Rapid Sequence Intubation in Emergency Situations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rapid Sequence Induction and Intubation in Anesthesia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rapid Sequence Intubation Pharmacology

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.